Significant Expansion of Healthcare Network and Strategic Achievements
In 2025, Akdital successfully expanded its healthcare network, establishing a presence across all 12 regions of Morocco. This expansion aligns with the company's initial goal of enhancing patient access to healthcare services. With a total of 41 facilities and 4,505 beds, the national network has become a tangible and operational reality, serving over 1.15 million admissions. Financially, Akdital has surpassed the milestone of 4 billion MAD in revenue for the first time, while maintaining a solid level of profitability despite the intensity of its investment program. Furthermore, 2025 marks the beginning of a new chapter in Akdital's international development, with active projects in Saudi Arabia, the United Arab Emirates, and Tunisia, aiming to establish a sustainable presence in these markets, as stated by Rochdi Talib, the Chief Executive Officer.
Robust Activity Growth and Territorial Commitment
During the fiscal year 2025, Akdital recorded a consolidated revenue of 4,413 million MAD, representing a remarkable growth of 49% compared to 2024. This increase is attributed to the contributions from facilities integrated in 2024 and 2025, as well as sustained growth from the existing operations. Both key sectors, multidisciplinary services and oncology, demonstrated balanced contributions, each experiencing a growth of 51% relative to the previous year. This financial success reflects the deepening territorial presence of the Group and the significant evolution of its medical activities. In 2025, Akdital catered to 566,077 patients, marking a 60% increase from 2024, with 62% of these services provided outside the Casablanca-Rabat axis. This distribution highlights the effectiveness of the Group's regional deployment and its tangible impact on healthcare access.
This operational efficiency is further evidenced in specialized medical fields. The Group performed 3,323 cardiovascular surgeries and 10,095 coronary dilatations, with 53% and 72% of these procedures conducted in regional settings, respectively. In oncology, 22,768 patients received treatment, 66% of whom were treated outside the Casablanca-Rabat corridor. Additionally, Akdital recorded 31,217 births across its facilities, accounting for 5.8% of national births, a significant increase from 2.8% in 2024. By the end of December 2025, the Group had 9,894 employees, with 61% under the age of 30, further affirming its role as a key player in employment within Morocco's private healthcare sector, especially at the regional level. The network also collaborates with 3,929 partner practitioners, with in-house physicians generating 75% of its revenue.
Consolidated EBITDA reached 1,214 million MAD in 2025, up by 45% compared to 2024, reflecting both operational growth and effective management. The EBITDA margin stood at 27.5%, slightly down from the previous year due to the ramp-up of new facilities. The consolidated net profit reached 494 million MAD, representing a 42% increase from 2024, with a net margin of 11.2%. The Group's net profit attributable to shareholders (RNPG) amounted to 444 million MAD.
Akdital invested 2,221 million MAD in consolidated net investments in fiscal year 2025, a 17% increase from 2024, covering the equipping of newly integrated facilities, modernization of existing infrastructure, and preparations for upcoming establishments, alongside 589 million MAD allocated to international projects, primarily related to land acquisition in Dubai and Riyadh, as well as the commencement of construction in Dubai. In line with the Group's 'asset-light' strategy, these real estate assets are intended to be sold to partner real estate companies, mirroring the successful model implemented in Morocco.
By the end of December 2025, consolidated net debt amounted to 4,268 million MAD (including 21% of debts related to capital expenditures), compared to 1,753 million MAD at the end of 2024. This increase accompanies the extensive development program undertaken throughout the fiscal year, primarily driven by the initiation of international expansion. It includes a bond issuance of 1.2 billion MAD aimed at financing international expansion and diversifying funding sources to optimize debt costs.
Looking ahead, Akdital intends to continue its expansion both nationally and internationally in the coming years. Domestically, the Group plans to broaden its presence with several openings anticipated by 2028, particularly in Inzegane, Al Hoceima, Khémisset, Taza, and Larache. Simultaneously, Akdital is developing 'Prime' formats in major cities, including Casablanca, Agadir, Tangier, and Fez. Internationally, the Group is now in an execution phase with two projects under development in the United Arab Emirates, particularly in Dubai. In Saudi Arabia, Akdital successfully acquired the Al Mishari Hospital in Riyadh, now rebranded as Akdital Hospitals Riyadh Olaya, and is moving forward with a memorandum of understanding for the acquisition of Bishri Hospital in Mecca. In Tunisia, the Group has signed an agreement to acquire 100% of Taoufik Hospitals Group, marking its first establishment in North Africa.
These operations remain subject to the usual regulatory approvals, expected to be secured during the first half of 2026. This expansion is supported by a dedicated organization, led by experienced local leaders with in-depth knowledge of their respective markets. For the fiscal year 2025, the Board of Directors has proposed to the Annual General Meeting the distribution of a dividend of 14 dirhams per share.
As reported by fnh.ma.
